Joincare Pharmaceutical Group Industry Co Ltd (600380) — Cash Flow Reinvestment Rate
Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting CN¥155.85 Million (capex CN¥155.85 Million ) from operating cash flow of CN¥1.09 Billion. Check Joincare Pharmaceutical Group Industry C earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Joincare Pharmaceutical Group Industry Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. Explore Joincare Pharmaceutical Group Industry C (600380) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Joincare Pharmaceutical Group Industry Co Ltd. For live market cap and broader valuation context, see 600380 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | CN¥2.06 Billion | CN¥3.89 Billion | CN¥767.20 Million | ▲ +71.7% |
| 2024 | 0.31x | CN¥1.12 Billion | CN¥3.64 Billion | CN¥979.13 Million | ▼ -39.6% |
| 2023 | 0.51x | CN¥2.01 Billion | CN¥3.93 Billion | CN¥1.13 Billion | ▼ -14.5% |
| 2022 | 0.60x | CN¥2.38 Billion | CN¥3.98 Billion | CN¥1.15 Billion | ▼ -27.1% |
| 2021 | 0.82x | CN¥2.10 Billion | CN¥2.56 Billion | CN¥1.52 Billion | ▲ +141.9% |
| 2020 | 0.34x | CN¥1.03 Billion | CN¥3.02 Billion | CN¥830.41 Million | ▼ -69.6% |
| 2019 | 1.11x | CN¥2.58 Billion | CN¥2.31 Billion | CN¥703.20 Million | ▼ -28.6% |
| 2018 | 1.56x | CN¥2.85 Billion | CN¥1.83 Billion | CN¥655.02 Million | ▲ +151.6% |
| 2017 | 0.62x | CN¥1.16 Billion | CN¥1.87 Billion | CN¥480.68 Million | ▼ -54.2% |
| 2016 | 1.35x | CN¥2.23 Billion | CN¥1.64 Billion | CN¥499.99 Million | ▲ +107.5% |
| 2015 | 0.65x | CN¥825.16 Million | CN¥1.26 Billion | CN¥594.33 Million | ▼ -21.8% |
| 2014 | 0.83x | CN¥816.97 Million | CN¥979.46 Million | CN¥816.97 Million | ▼ -46.1% |
| 2013 | 1.55x | CN¥983.83 Million | CN¥635.52 Million | CN¥983.83 Million | ▲ +31.7% |
| 2012 | 1.18x | CN¥863.48 Million | CN¥734.36 Million | CN¥863.48 Million | ▲ +73.8% |
| 2011 | 0.68x | CN¥440.12 Million | CN¥650.36 Million | CN¥440.12 Million | ▲ +28.0% |
| 2010 | 0.53x | CN¥584.47 Million | CN¥1.11 Billion | CN¥584.47 Million | ▲ +4.4% |
| 2009 | 0.51x | CN¥306.87 Million | CN¥605.66 Million | CN¥306.87 Million | ▲ +5.9% |
| 2008 | 0.48x | CN¥217.71 Million | CN¥455.01 Million | CN¥217.71 Million | ▼ -16.7% |
| 2007 | 0.57x | CN¥246.63 Million | CN¥429.26 Million | CN¥246.63 Million | ▼ -68.1% |
| 2006 | 1.80x | CN¥490.19 Million | CN¥272.50 Million | CN¥490.19 Million | ▲ +77.6% |
| 2005 | 1.01x | CN¥367.73 Million | CN¥363.13 Million | CN¥367.73 Million | ▲ +11.3% |
| 2004 | 0.91x | CN¥219.90 Million | CN¥241.71 Million | CN¥219.90 Million | ▲ +41.7% |
| 2003 | 0.64x | CN¥110.60 Million | CN¥172.25 Million | CN¥110.60 Million | ▲ +64.6% |
| 2002 | 0.39x | CN¥92.09 Million | CN¥236.13 Million | CN¥92.09 Million | ▲ +25.5% |
| 2001 | 0.31x | CN¥69.55 Million | CN¥223.79 Million | CN¥69.55 Million | ▼ -23.2% |
| 2000 | 0.40x | CN¥69.46 Million | CN¥171.61 Million | CN¥69.46 Million | ▼ -9.6% |
| 1999 | 0.45x | CN¥49.15 Million | CN¥109.82 Million | CN¥49.15 Million | — |